OpenURL Connection Search

Select item for more details and to access through your institution.

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature.
Published in:
2009
By:
- Salama, A.;
- Rieke, M.;
- Kiesewetter, H.;
- Depka, M.;
- von Depka, M
Publication type:
journal article
Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
Published in:
Gene Therapy, 2003, v. 10, n. 22, p. 1917, doi. 10.1038/sj.gt.3302093
By:
- Tiede, A.;
- Eder, M.;
- von Depka, M.;
- Battmer, K.;
- Luther, S.;
- Kiem, H-P.;
- Ganser, A.;
- Scherr, M.
Publication type:
Article
Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.
Published in:
European Journal of Pediatrics, 1999, v. 158, n. 15, p. S143, doi. 10.1007/PL00014341
By:
- Wermes, C.;
- Prondzinski, M. Depka;
- Lichtinghagen, R.;
- Barthels, M.;
- Welte, K.;
- Sykora, K.-W.
Publication type:
Article
Diagnostic potential and limitations of thrombelastography/-metry.
Published in:
2007
By:
- Lang T;
- von Depka M
Publication type:
Journal Article
Potentielle genetische Polymorphismen der venösen Thromboembolic.
Published in:
Journal of Laboratory Medicine / Laboratoriums Medizin, 2001, v. 25, n. 7/8, p. 277
By:
- von Depka, M.;
- Ehrenforth, Silke
Publication type:
Article
The Role of Factor XIII Val34Leu Polymorphism in Thrombotic Disease.
Published in:
Journal of Laboratory Medicine / Laboratoriums Medizin, 2001, v. 25, n. 7/8, p. 254
By:
- Ehrenforth, Silke;
- von Depka, M.
Publication type:
Article
Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates.
Published in:
Annals of the New York Academy of Sciences, 2005, v. 1051, n. 1, p. 498, doi. 10.1196/annals.1361.094
By:
- AUER, CH;
- OLDENBURG, J.;
- DEPKA, M.;
- ESCURIOLA‐ETTINGHAUSEN, C.;
- KURNIK, K.;
- LENK, H.;
- SCHARRER, I.
Publication type:
Article
Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.
Published in:
Journal of Medical Virology, 1996, v. 48, n. 4, p. 339, doi. 10.1002/(SICI)1096-9071(199604)48:4<339::AID-JMV7>3.0.CO;2-8
By:
- Berger, A.;
- Prondzinski, M. v. Depka;
- Doerr, H.W.;
- Rabenau, H.;
- Weber, B.
Publication type:
Article
Factor VIII Inhibitor‐Tests Could Be Less Sensitive Than Supposed.
Published in:
Vox Sanguinis, 1999, v. 77, p. 87, doi. 10.1111/j.1423-0410.1999.tb00023.x
By:
- Bartheis, M.;
- Kraus, M.;
- Bohn, U.;
- Liese, B.;
- von Depka, M.;
- Eisert, R.;
- Ganser, A.
Publication type:
Article
Factor VIII Inhibitor-Tests Could Be Less Sensitive Than Supposed.
Published in:
Vox Sanguinis, 1999, v. 77, p. 87, doi. 10.1159/000056725
By:
- Barthels, M.;
- Kraus, M.;
- Bohn, U.;
- Liese, B.;
- von Depka, M.;
- Eisert, R.;
- Ganser, A.
Publication type:
Article
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
Published in:
Haemophilia, 2007, v. 13, n. 1, p. 38, doi. 10.1111/j.1365-2516.2006.01403.x
By:
- ASTERMARK, J.;
- ROCINO, A.;
- VON DEPKA, M.;
- VAN DEN BERG, H. M.;
- GRINGERI, A.;
- MANTOVANI, L. G.;
- MORADO, M.;
- GARRIDO, R. P.;
- SCHIAVONI, M.;
- VILLAR, A.;
- WINDYGA, J.
Publication type:
Article
Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Published in:
Haemophilia, 2006, v. 12, n. 4, p. 363, doi. 10.1111/j.1365-2516.2006.01296.x
By:
- Astermark, J.;
- Morado, M.;
- Rocino, A.;
- Van Den Berg, H. M.;
- Von Depka, M.;
- Gringeri, A.;
- Mantovani, L.;
- Garrido, R. P.;
- Schiavoni, M.;
- Villar, A.;
- Windyga, J.
Publication type:
Article
Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.
Published in:
Haemophilia, 2005, v. 11, p. 18, doi. 10.1111/j.1365-2516.2005.01157.x
By:
- von Depka, M.
Publication type:
Article
Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.
Published in:
Haemophilia, 2005, v. 11, p. 18, doi. 10.1111/j.1365-2516.2005.01157.x
By:
- Von Depka, M.
Publication type:
Article
Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.
Published in:
Haemophilia, 2004, v. 10, n. 5, p. 499, doi. 10.1111/j.1365-2516.2004.00950.x
By:
- Auerswald, G.;
- Prondzinski, M. Von Depka;
- Ehlken, B.;
- Kreuz, W.;
- Kurnik, K.;
- Lenk, H.;
- Scharrer, I.;
- Schramm, W.;
- Zimmermann, R.
Publication type:
Article
Hämostasestörungen bei onkologischen Patienten.
Published in:
Der Internist, 2005, v. 46, n. 1, p. 48, doi. 10.1007/s00108-004-1329-x
By:
- Depka Prondzinski, M.
Publication type:
Article
Fifth Åland Island conference on von Willebrand disease.
Published in:
Haemophilia, 2018, v. 24, p. 5, doi. 10.1111/hae.13475
By:
- Berntorp, E.;
- Ågren, A.;
- Aledort, L.;
- Blombäck, M.;
- Cnossen, M. H.;
- Croteau, S. E.;
- von Depka, M.;
- Federici, A. B.;
- Goodeve, A.;
- Goudemand, J.;
- Mannucci, P. M.;
- Mourik, M.;
- Önundarson, P. T.;
- Rodeghiero, F.;
- Szántó, T.;
- Windyga, J.
Publication type:
Article
Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.
Published in:
Haemophilia, 2018, v. 24, n. 1, p. 70, doi. 10.1111/hae.13351
By:
- Zozulya, N.;
- Kessler, C. M.;
- Klukowska, A.;
- von Depka, M.;
- Hampton, K.;
- Hay, C. R. M.;
- Jansen, M.;
- Bichler, J.;
- Knaub, S.;
- Rangarajan, S.
Publication type:
Article
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A.
Published in:
Haemophilia, 2016, v. 22, n. 5, p. 730, doi. 10.1111/hae.12985
By:
- Klamroth, R.;
- Simpson, M.;
- Depka ‐ Prondzinski, M.;
- Gill, J. C.;
- Morfini, M.;
- Powell, J. S.;
- Santagostino, E.;
- Davis, J.;
- Huth ‐ Kühne, A.;
- Leissinger, C.;
- Neumeister, P.;
- Bensen ‐ Kennedy, D.;
- Feussner, A.;
- Limsakun, T.;
- Zhou, M.;
- Veldman, A.;
- St. Ledger, K.;
- Blackman, N.;
- Pabinger, I.
Publication type:
Article
Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety.
Published in:
Haemophilia, 2016, v. 22, n. 2, p. 225, doi. 10.1111/hae.12793
By:
- Lissitchkov, T.;
- Hampton, K.;
- Depka, M.;
- Hay, C.;
- Rangarajan, S.;
- Tuddenham, E.;
- Holstein, K.;
- Huth‐Kühne, A.;
- Pabinger, I.;
- Knaub, S.;
- Bichler, J.;
- Oldenburg, J.
Publication type:
Article
von Willebrand's disease: a report from a meeting in the Åland islands.
Published in:
Haemophilia, 2012, v. 18, p. 1, doi. 10.1111/j.1365-2516.2012.02925.x
By:
- Berntorp, E.;
- Peake, I.;
- Budde, U.;
- Laffan, M.;
- Montgomery, R.;
- Windyga, J.;
- Goodeve, A.;
- Petrini, P.;
- Depka, M.;
- Miesbach, W.;
- Lillicrap, D.;
- Federici, A. B.;
- Lassila, R.;
- White, G.
Publication type:
Article
Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.
Published in:
Haemophilia, 2010, v. 16, n. 5, p. 747, doi. 10.1111/j.1365-2516.2010.02231.x
By:
- ASTERMARK, J.;
- ALTISENT, C.;
- BATOROVA, A.;
- DINIZ, M. J.;
- GRINGERI, A.;
- HOLME, P. A.;
- KARAFOULIDOU, A.;
- LOPEZ-FERNÁNDEZ, M. F.;
- REIPERT, B. M.;
- ROCINO, A.;
- SCHIAVONI, M.;
- von DEPKA, M.;
- WINDYGA, J.;
- FIJNVANDRAAT, K.
Publication type:
Article
European curriculum for thrombosis and haemostasis.
Published in:
Haemophilia, 2009, v. 15, n. 1, p. 337, doi. 10.1111/j.1365-2516.2008.01836.x
By:
- ASTERMARK, J.;
- NEGRIER, C.;
- HERMANS, C.;
- HOLME, P. A.;
- KLAMROTH, R.;
- KOTSI, P.;
- DE MOERLOOSE, P.;
- PASI, J.;
- ROCINO, A.;
- VON DEPKA, M.;
- WINDYGA, J.;
- LUDLAM, C. A.
Publication type:
Article
Canine hemophilia A caused by a mutation leading to a stop codon.
Published in:
Veterinary Record: Journal of the British Veterinary Association, 2011, v. 169, n. 19, p. 496, doi. 10.1136/vr.d4677
By:
- Mischke, R.;
- Wilhelm, Ch.;
- Czwalinna, A.;
- Varvenne, M.;
- Narten, K.;
- von Depka, M.
Publication type:
Article

Found: 24

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature.

Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.

Clinical relevance of genetic risk factors for thrombosis in paediatric oncology patients with central venous catheters.

Diagnostic potential and limitations of thrombelastography/-metry.

Potentielle genetische Polymorphismen der venösen Thromboembolic.

The Role of Factor XIII Val34Leu Polymorphism in Thrombotic Disease.

Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates.

Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.

Factor VIII Inhibitor‐Tests Could Be Less Sensitive Than Supposed.

Factor VIII Inhibitor-Tests Could Be Less Sensitive Than Supposed.

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.

Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany.

Hämostasestörungen bei onkologischen Patienten.

Fifth Åland Island conference on von Willebrand disease.

Efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures.

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate<sup>®</sup>) in patients with severe haemophilia A.

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq<sup>®</sup>) in adults with severe haemophilia A: efficacy and safety.

von Willebrand's disease: a report from a meeting in the Åland islands.

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report.

European curriculum for thrombosis and haemostasis.

Canine hemophilia A caused by a mutation leading to a stop codon.